BCLI•benzinga•
BrainStorm Cell Therapeutics Has Been Granted The Exact Compliance Extension It Requested From The Nasdaq Hearings Panel Through June 30, 2025, To Regain Compliance With Certain Continued Listing Standards Of The Nasdaq Capital Market
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga